BRANDI JOHNSON: Open Payments
NPI 1225398928 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 46 payments from 17 companies in 2025. Trend: 2023 $1,072 · 2024 $849 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| ABBVIE INC. | 13 | $146 |
| Novo Nordisk Inc | 4 | $95 |
| Lilly USA, LLC | 4 | $79 |
| Dexcom, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Esperion Therapeutics, Inc. | 2 | $29 |
Products named: AIRSUPRA, MOUNJARO, FARXIGA, VRAYLAR, UBRELVY, Wegovy, Dexcom G6 Transmitter, Kerendia.
Industry payments across GA — which companies pay providers there.
